TY - JOUR T1 - Safety of intravenous immunoglobulin treatment. JF - Journal of Clinical Pathology JO - J Clin Pathol SP - 1192 LP - 1193 DO - 10.1136/jcp.38.10.1192 VL - 38 IS - 10 AU - H I Atrah AU - R J Crawford AU - B C Dow AU - R Mitchell Y1 - 1985/10/01 UR - http://jcp.bmj.com/content/38/10/1192.abstract N2 - In a prospective clinical and biochemical study of 16 patients treated with high doses of an immunoglobulin product that had been modified for intravenous use by mild pepsin treatment at pH 4 no evidence of hepatitis could be found. This contrasts with recent reports that intravenous immunoglobulin products can apparently transmit non-A, non-B hepatitis. ER -